Ortho Clinical Diagnostics Earns CE Mark Approval

June 21, 2016

Ortho Clinical Diagnostics has nabbed CE mark approval for its VITROS HIV combo test, the Raritan, N.J.-based company announced Tuesday.

The test is intended for the detection of both HIV-1 and HIV-2 antibodies and the p24 antigen.

The new addition expands the company’s existing infectious disease portfolio. — Anisa Jibrell

View today's stories